Using a fitness tracker to enhance health in Black prostate cancer survivors
Bridging the Digital Divide of Wearables to Improve Health Outcomes and Quality of Life Among Black Prostate Cancer (CaP) Survivors
This study is testing if using a fitness tracker can help Black prostate cancer survivors be more active, improve their body health, and feel better overall.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Mayo Clinic Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Jacksonville, Florida and 1 other locations) |
| Trial ID | NCT06703996 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the InBody Band 3 fitness tracker in improving physical activity, body composition, and overall quality of life among Black prostate cancer survivors. Participants will wear the tracker continuously and engage in weekly check-in discussions for six weeks to set goals and monitor progress. The study aims to assess both the feasibility and acceptability of this remote wearables-based intervention in this specific population, addressing a gap in evidence regarding their physical activity and health outcomes.
Who should consider this trial
Good fit: Ideal candidates include Black men aged 18 and older who have been diagnosed with stage I-IV prostate cancer and are willing to use a fitness tracker.
Not a fit: Patients currently undergoing adjunct cancer therapy or those living outside the United States may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could lead to improved physical health and quality of life for Black prostate cancer survivors.
How similar studies have performed: Other studies have shown positive outcomes using wearable health technology in various patient populations, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to read/speak English and are able to communicate by phone * 18 years of age or older * Self-identify as Black * Have been diagnosed with stage I-IV prostate cancer * Have an active email address and are able to regularly check emails for electronic surveys * Own and are willing to use a personal smartphone with regular/reliable access to the internet to sync regularly with a fitness tracker * Are willing to wear and use a smart fitness tracker for 6 weeks and allow sharing of their fitness data with the study team * Are not currently undergoing adjunct cancer therapy (e.g. chemotherapy, radiation) during the 6 weeks of study participation, except oral tyrosine kinase inhibitor or hormonal therapies; and * Are an existing Mayo patient * Self-report that they would like to improve their physical activity during initial study coordinator contact Exclusion Criteria: * Live outside of the United States (U.S) * Have an implanted medical device (e.g., pacemaker, etc.) or a life-sustaining device (e.g., patient monitoring device) * Have a self-reported history of a psychiatric disorder(s) or moderate to severe cognitive impairment precluding participation in the study intervention or preventing the ability to provide independent informed consent * Are on prolonged bed rest (i.e., more than half of the waking day in bed) by self-report * Currently have any lower extremity injury that impedes them from engaging in walking for one block * Are unable to walk for at least one block without a walking aide by self-report; or * Regularly use a wheelchair for mobility by self-report
Where this trial is running
Jacksonville, Florida and 1 other locations
- Mayo Clinic in Florida — Jacksonville, Florida, United States (Active_not_recruiting)
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Emma Fortune Ngufor, PhD — Mayo Clinic in Rochester
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.